Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1Phase 3 1Phase 2 1

Status

Withdrawn 1Suspended 1Completed 1

Sponsor Class

OTHER 2NETWORK 1

Study Type

Interventional 3

Sponsor

Cancer Type

Lymphoid 3Other hematologic neoplasm 1CNS 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 235Lymphoma 160Leukemia 109Burkitt Lymphoma 91Lymphoma, Non-Hodgkin 85Lymphoma, Large B-Cell, Diffuse 80Lymphoma, Mantle-Cell 70Leukemia, Myeloid, Acute 53Lymphoma, Follicular 49Hodgkin Disease 44Lymphoma, Large-Cell, Immunoblastic 37Leukemia, Lymphocytic, Chronic, B-Cell 33Recurrence 32Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 28Lymphoma, B-Cell, Marginal Zone 24Leukemia, Biphenotypic, Acute 24Myelodysplastic Syndromes 23Blast Crisis 19Lymphoma, Large-Cell, Anaplastic 18Lymphoma, B-Cell 18Dendritic Cell Sarcoma, Interdigitating 17Congenital Abnormalities 17Leukemia, Myeloid, Accelerated Phase 16Leukemia, Myelomonocytic, Chronic 15Multiple Myeloma 12Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 11Lymphoma, T-Cell 11Myeloproliferative Disorders 10Anemia, Refractory, with Excess of Blasts 10Neoplasms, Plasma Cell 9

Interventions

Vincristine 4Radiotherapy 3Procarbazine 3Methotrexate 3Cytarabine 3Rituximab 2Prednisolone 2Cyclophosphamide 2motexafin gadolinium 1glutamic acid diethyl ester 1glucarpidase 1fludarabine phosphate 1fludarabine 1axicabtagene ciloleucel 1Simvastatin 1Neuropsychological Tests 1Methylprednisolone 1Magnetic Resonance Spectroscopy 1Leucovorin 1Interleukin 1 Receptor Antagonist Protein 1Glutamine 1Glutamic Acid 1Etoposide 1Doxorubicin 1Dietary Supplements 1Dexamethasone 1Contrast Media 1Bendamustine Hydrochloride 1Baclofen 1AP 1903 reagent 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Neurotoxicity Syndromes × Cytarabine × Lymphoid × Clear all
NCT01399372 2023-07-20

Rituximab, Methotrexate, Vincristine Sulfate, Procarbazine Hydrochloride, and Cytarabine With or Without Radiation Therapy in Treating Patients With Primary Central Nervous System Lymphoma

Radiation Therapy Oncology Group

Phase 2 Completed
91 enrolled 17 charts
Lymphoid

Lymphoma, Radiation Injuries, Neurotoxicity Syndromes

NCT00991744 2012-10-10

Liposomal Cytarabine for Central Nervous System (CNS)-Treatment in High-risk Acute Lymphoblastic Leukemia (ALL)

Nordic Society for Pediatric Hematology and Oncology

Phase 3 Suspended
100 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Neurotoxicity Syndromes, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00734773 2012-05-18

Pilot Study of MGd + High-dose MTX-Based Chemoimmunotherapy + RT for Newly Dx PCNSL

Northwestern University

Phase EARLY_PHASE1 Withdrawn
CNSLymphoid

Lymphoma, Central Nervous System Neoplasms, Neurotoxicity Syndromes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡